Conflicting recommendations: A labyrinth for the clinician and patients: A comment to Eisenberg's et al. "medical cannabis for chronic pain"
- PMID: 36317603
- DOI: 10.1002/ejp.2050
Conflicting recommendations: A labyrinth for the clinician and patients: A comment to Eisenberg's et al. "medical cannabis for chronic pain"
Comment on
-
Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations.Eur J Pain. 2022 Jul;26(6):1183-1185. doi: 10.1002/ejp.1946. Epub 2022 Apr 6. Eur J Pain. 2022. PMID: 35363933 Free PMC article. No abstract available.
References
REFERENCES
-
- Bell, R. F., & Kalso, E. A. (2021). Cannabinoids for pain or profit? Pain, 162, S125-s126.
-
- Eisenberg, E., Morlion, B., Brill, S., & Häuser, W. (2022). Medicinal cannabis for chronic pain: The Bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations. European Journal of Pain, 26, 1183-1185.
-
- Fisher, E., Moore, R. A., Fogarty, A. E., Finn, D. P., Finnerup, N. B., Gilron, I., Haroutounian, S., Krane, E., Rice, A. S. C., Rowbotham, M., Wallace, M., & Eccleston, C. (2021). Cannabinoids, cannabis, and cannabis-based medicine for pain management: A systematic review of randomised controlled trials. Pain, 162, S45-s66.
-
- Häuser, W., Finn, D. P., Kalso, E., Krcevski-Skvarc, N., Kress, H. G., Morlion, B., Perrot, S., Schäfer, M., Wells, C., & Brill, S. (2018). European pain federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. European Journal of Pain, 22, 1547-1564.
-
- IASP. (2021). International Association for the Study of Pain presidential task force on cannabis and cannabinoid analgesia position statement. Pain, 162, S1-s2.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
